Issues and updates: evaluating estrogen receptor-alpha, progesterone receptor, and HER2 in breast cancer.
about
GPER Function in Breast Cancer: An OverviewEstrogen receptor alpha gene amplification in breast cancer: 25 years of debateIdentifying and targeting tumor-initiating cells in the treatment of breast cancerTFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer.Insights into the key roles of proteoglycans in breast cancer biology and translational medicineHormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries.Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis.The role of the pathologist in the decision-making process.HER2/neu Testing In 432 Consecutive Breast Cancer Cases using FISH and IHC - A Comparative Study.Palmitoylation: a protein S-acylation with implications for breast cancer.Use of a single hybrid imaging agent for integration of target validation with in vivo and ex vivo imaging of mouse tumor lesions resembling human DCISNeogenin expression is inversely associated with breast cancer grade in ex vivo.Triple-negative breast cancer: new perspectives for targeted therapies.Benzene-poly-carboxylic acid complex, a novel anti-cancer agent induces apoptosis in human breast cancer cells.HER-2 assessment in formalin-fixed paraffin-embedded breast cancer tissue by well-based reverse phase protein arraySyndecan-1 and syndecan-4 are independent indicators in breast carcinomaP53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesisPositive correlation between expression level of mitochondrial serine hydroxymethyltransferase and breast cancer grade.Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans.ER-α36, a novel isoform of ER-α66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast.Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy.Update on triple-negative breast cancer: prognosis and management strategiesOverexpression of caspase 7 is ERα dependent to affect proliferation and cell growth in breast cancer cells by targeting p21(Cip).Protocol for Biomarker Ratio Imaging Microscopy with Specific Application to Ductal Carcinoma In situ of the Breast.Psammoma bodies in fine needle aspiration cytology of the breast: a clinicopathological study of 30 cases.A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative.Hormone receptor expression in breast cancer: postanalytical issues.Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells.Gene amplification of ESR1 in breast cancers--fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study.Tumor Phenotype and Gene Expression During Early Mammary Tumor Development in Offspring Exposed to Alcohol In Utero.Oestrogen receptor/progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer: a 9-year study at Princess Noorah Oncology Center, Saudi Arabia.Calpain-1 is associated with adverse relapse free survival in breast cancer: a confirmatory study.Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.Detection and evaluation of estrogen DNA-adducts and their carcinogenic effects in cultured human cells using biotinylated estradiol.Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study.Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women.The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: The Pendulum between Survival and Death in Breast Cancer?
P2860
Q21131274-3B1BFC15-100A-4434-82F3-B8221E830632Q24273274-C21955BE-1004-44C2-A90B-08686B234C34Q26851827-E41D9F61-127C-448F-90AF-B590395B67F8Q27853155-237B3AE3-10A1-47E1-AFD0-0894540DF68FQ28085548-7D140BA6-3F7A-46F9-85F9-DB79E381B4D1Q31120324-DAFEC84D-04A3-484C-8EDB-EDDF5E1F02BEQ33587654-2AAFB717-607E-43AD-A1E5-2AAB6C8B591FQ33697907-263A72F4-0F02-45BB-BFD6-C6BE5590B84EQ33741544-C1249D05-F265-4B83-82AE-CCC3210482A0Q33915087-39A6AC09-A1C5-43C1-92F3-26F6AE34C655Q34550833-34BEB41C-AA8B-46B8-99E0-D38D2B56E149Q34636370-07669B84-1AF0-41B2-845E-7CBAFB7C15D8Q35001758-F74334FC-6D85-4062-BECD-8F503AE55861Q35093497-8E36E79E-F1DF-42AC-988E-E14B23B79EF1Q35184966-B4C672A7-07B7-4B4A-BE11-A312E9BDF5E6Q35441324-447F637E-5369-4E01-AD66-29C401572869Q35455993-249419BA-7E91-48D4-BFDF-BFF5D6313C85Q35624231-9B4A2A63-5585-4FF9-80C5-3FF760B5DA08Q35768137-650E180E-5692-470D-B0F9-8782245DA712Q36048992-D6EA5D84-794D-4B53-BD48-C4D19D96C859Q36105964-046C68E0-58CF-4379-904F-32432FD302FDQ36311616-F9786C65-1708-45CB-889E-76391D37D2AEQ36846714-CB3494DF-3327-442C-92A8-51F79AFFDE28Q37389535-B9B01BEE-49EB-4183-873D-215AD9FFAE72Q37965103-8ED1F93C-31CF-4FE4-863B-9EF19E45BDA1Q38030881-05F5F1CC-1BF6-447E-A67B-DF69289488B7Q38092775-6B0454EB-42A9-4EB3-8336-B3259C12C2B5Q39016637-697984F5-DCBF-4235-B127-2FEC1184C67EQ39428484-1AC2EA88-4AD0-4596-B3E4-3579E8B24538Q39636088-F58F9A9D-3FDE-48E9-8B9F-6823007C32EEQ39739835-FB53FBED-F411-4C54-B69F-15890CD3FB80Q40397797-0EAE4771-D76C-465C-B46E-5EB90476981FQ44645468-08190FAB-7FCC-414E-987A-EAC59293107AQ48008739-0E560CA2-E3E9-4213-A17A-3B0DDF62602DQ48353102-A2237653-86FB-4010-A4F8-A5B5A667F849Q51663878-19DB43F9-63F0-4CA3-8997-9416A3CB795EQ53095268-FDACBD4B-40AC-428A-B030-A76001C7587EQ54118354-138135E4-B9D0-4368-926A-2A14B393FC8DQ54337921-5F6A06C4-25A7-4BAF-B61E-D79DBD82B89AQ55509868-57F2CF22-D2AE-4BE3-83CC-25877D9F6307
P2860
Issues and updates: evaluating estrogen receptor-alpha, progesterone receptor, and HER2 in breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Issues and updates: evaluating ...... or, and HER2 in breast cancer.
@en
Issues and updates: evaluating ...... or, and HER2 in breast cancer.
@nl
type
label
Issues and updates: evaluating ...... or, and HER2 in breast cancer.
@en
Issues and updates: evaluating ...... or, and HER2 in breast cancer.
@nl
prefLabel
Issues and updates: evaluating ...... or, and HER2 in breast cancer.
@en
Issues and updates: evaluating ...... or, and HER2 in breast cancer.
@nl
P2860
P1433
P1476
Issues and updates: evaluating ...... or, and HER2 in breast cancer.
@en
P2093
D Craig Allred
P2860
P2888
P356
10.1038/MODPATHOL.2010.55
P478
23 Suppl 2
P577
2010-05-01T00:00:00Z